PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Antibody Therapeutics is an official journal of the Chinese Antibody Society and published by the Oxford University Press. As a peer-reviewed and open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery research, translational development and methodology of therapeutic antibodies for global scientific community. Antibody Therapeutics is currently indexed by Scopus and PubMed Central. Authors can publish in the journal with no charge.